Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs. obatoclax
Margarita Espona‐Fiedler(Umeå University), Ricardo Pérez‐Tomás(Bellvitge University Hospital), Vanessa Soto‐Cerrato(Institut d'Investigació Biomédica de Bellvitge), Roberto Quesada(Universidad de Burgos), A. Hosseini(Institució Catalana de Recerca i Estudis Avançats), Vı́ctor Guallar(Institució Catalana de Recerca i Estudis Avançats), Tianyan Gao(University of Kentucky), José M. Lizcano(Universitat Autònoma de Barcelona)
Cited by 74
Related Papers
Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer
|Cell Death and Disease|2017|284
Oxidoreductases on their way to industrial biotransformations
|Biotechnology Advances|2017|280
Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer
|Cell Death and Disease|2018|226
MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma
|Modern Pathology|2014|174
Determinants and Prediction of Esterase Substrate Promiscuity Patterns
|ACS Chemical Biology|2017|146